appointments

News

Prof Jonathan Benger will take over from Dr Sam Roberts as CEO of UK reimbursement authority NICE later this week, at a critical time for the agency.

News

Tracy Beth Høeg, who has very little regulatory experience, is making the switch from CBER to replace FDA veteran Richard Pazdur.

R&D

From high-profile resignations to the addition of seasoned executives and scientific leaders, last month saw a series of notable changes.

Digital

In the digital and supplier space, we saw a good deal of personnel movement in October, including a number of CEO appointments.

R&D

From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.

News

After 12 years as CEO of 'techbio' player Recursion, Chris Gibson is switching to the role of chair and will be replaced by Najat Khan.